Howard Mayer serves as Executive at Entasis Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Howard Mayer has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 11, 2022 involved selling 27,500 shares valued at $60.5K.
Howard Mayer currently holds 49,500 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Howard Mayer has been a net neutral trader of ETTX stock. They have purchased $0 and sold $0 worth of shares.
Howard Mayer's most recent insider trade was on Jul 11, 2022, when they sold 27,500 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| 22,000 |
| $2.20 |
| Discretionary |
| Jan 18, 2022 | ETTX | $0 | Award | 27,500 | $N/A | Discretionary |
| Apr 1, 2021 | ETTX | $0 | Award | 22,000 | $N/A | Discretionary |